Cornual fibroids: a conservative approach to restoring tubal patency using a gonadotropin-releasing hormone agonist (goserelin) with successful pregnancy.
The administration of GnRH agonists to shrink fibroids, albeit temporarily, may be of benefit to those patients in whom tubal blockage by the fibroids has given rise to infertility. Tubal patency has been restored in two of our patients, resulting in pregnancy in one.
Gardner
R L
RL
Department of Obstetrics and Gynaecology, Royal Free Hospital, Pond Street, London, United Kingdom.
Shaw
R W
RW
D000328:Adult; D002064:Buserelin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005186:Fallopian Tube Patency Tests; D005187:Fallopian Tubes / Q000187:drug effects* / Q000503:physiopathology; D005260:Female; D005350:Fibroma / Q000188:drug therapy*; D017273:Goserelin; D006801:Humans; D011247:Pregnancy; D014594:Uterine Neoplasms / Q000188:drug therapy*
D017273:Goserelin; D002064:Buserelin